Search research articles
Contact Us
Filters
Showing results (121-130 of 188) with videos related to
Page
of 19
Sort By:
Circulation
|
November 10, 2025
Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial
William F Fearon, Kosei Terada, Kuniaki Takahashi, et al.
The Lancet. Diabetes & Endocrinology
|
December 21, 2025
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
Frederick J Raal, Jean Bergeron, Daniel Gaudet, et al.
Circulation. Genomic and Precision Medicine
|
February 10, 2022
Coronary Artery Disease Risk of Familial Hypercholesterolemia Genetic Variants Independent of Clinically Observed Longitudinal Cholesterol Exposure
Shoa L Clarke, Catherine Tcheandjieu, Austin T Hilliard, et al.
Nature Medicine
|
August 25, 2023
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts
Gerald F Watts, Christian Schwabe, Russell Scott, et al.
Circulation
|
July 21, 2022
Creation of the American Heart Association Journals' Equity, Diversity, and Inclusion Editorial Board: The Next Step to Achieving the 2024 Impact Goal
Eldrin F Lewis, Christine Beaty, Johannes Boltze, et al.
The Journal of Pediatrics
|
September 25, 2020
Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry
Sarah D de Ferranti, Peter Shrader, MacRae F Linton, et al.
Human Molecular Genetics
|
April 30, 2008
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study
Themistocles L Assimes, Joshua W Knowles, Analabha Basu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
March 23, 2025
Primary care providers' perspectives on receiving opportunistic genomic results from a national study: The Million Veteran Program Return Of Actionable Results (MVP-ROAR) Study
Anna L Johannsen, Morgan E Danowski, Kailyn E Sitter, et al.
NEJM Evidence
|
February 6, 2024
RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia
Daniel Gaudet, Peter Clifton, David Sullivan, et al.
NPJ Digital Medicine
|
July 16, 2019
Finding missed cases of familial hypercholesterolemia in health systems using machine learning
Juan M Banda, Ashish Sarraju, Fahim Abbasi, et al.
Page
of 19
Search research articles
Search
Showing results (121-130 of 188) with videos related to
Sort By:
Page
of 19
Circulation
|
November 10, 2025
Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial
William F Fearon, Kosei Terada, Kuniaki Takahashi, et al.
The Lancet. Diabetes & Endocrinology
|
December 21, 2025
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
Frederick J Raal, Jean Bergeron, Daniel Gaudet, et al.
Circulation. Genomic and Precision Medicine
|
February 10, 2022
Coronary Artery Disease Risk of Familial Hypercholesterolemia Genetic Variants Independent of Clinically Observed Longitudinal Cholesterol Exposure
Shoa L Clarke, Catherine Tcheandjieu, Austin T Hilliard, et al.
Nature Medicine
|
August 25, 2023
RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts
Gerald F Watts, Christian Schwabe, Russell Scott, et al.
Circulation
|
July 21, 2022
Creation of the American Heart Association Journals' Equity, Diversity, and Inclusion Editorial Board: The Next Step to Achieving the 2024 Impact Goal
Eldrin F Lewis, Christine Beaty, Johannes Boltze, et al.
The Journal of Pediatrics
|
September 25, 2020
Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry
Sarah D de Ferranti, Peter Shrader, MacRae F Linton, et al.
Human Molecular Genetics
|
April 30, 2008
Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study
Themistocles L Assimes, Joshua W Knowles, Analabha Basu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
March 23, 2025
Primary care providers' perspectives on receiving opportunistic genomic results from a national study: The Million Veteran Program Return Of Actionable Results (MVP-ROAR) Study
Anna L Johannsen, Morgan E Danowski, Kailyn E Sitter, et al.
NEJM Evidence
|
February 6, 2024
RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia
Daniel Gaudet, Peter Clifton, David Sullivan, et al.
NPJ Digital Medicine
|
July 16, 2019
Finding missed cases of familial hypercholesterolemia in health systems using machine learning
Juan M Banda, Ashish Sarraju, Fahim Abbasi, et al.
Page
of 19